Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
46.30
0.00 (0.00%)
Dec 31, 2025, 4:00 PM EST - Market closed
Soleno Therapeutics Market Cap
Soleno Therapeutics has a market cap or net worth of $2.49 billion as of December 31, 2025. Its market cap has increased by 23.47% in one year.
Market Cap
2.49B
Enterprise Value
1.98B
1-Year Change
23.47%
Ranking
Category
Stock Price
$46.30
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $2.49B, an increase of 9,967.91%. That is a compound annual growth rate of 51.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 2.49B | 28.31% |
| Dec 31, 2024 | 1.94B | 57.88% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
| Nov 13, 2014 | 24.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |